Wouter de Herder

Professor of Endocrine Oncology

Erasmus University Rotterdam

Netherlands

Research Interests

Explore related searches

Professors in Netherlands Professors in Cancer Biology Cancer Biology professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Wouter de Herder is a Professor of Endocrine Oncology at Erasmus University Rotterdam in the Netherlands. His research focuses on various aspects of neuroendocrine tumors, insulinoma, and related syndromes, as evidenced by his recent articles addressing topics such as carcinoid syndrome and peptide receptor radionuclide therapy. He has contributed significantly to the understanding of metabolic disorders in the context of endocrine oncology.

Articles (21)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (7)

Robert Kraaij

Assistant Professor

Erasmus MC

NETHERLANDS

View details

Marco Volante

ITALY

View details

Emanuel Christ

University Hospital Basel

SWITZERLAND

View details

Leo Hofland

Erasmus University Rotterdam

NETHERLANDS

View details

Lodewijk Brosens

UMC Utrecht

NETHERLANDS

View details

Jens Otto Lunde Jørgensen

Aarhus University Hospital

DENMARK

View details

Julie Refardt

University Hospital Basel

SWITZERLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Wouter de Herder

Research Interests

Explore related searches

Contact this professor

About

Articles (21)

A new link between insulinoma and congenital glucose-galactose malabsorption

Thomas Hardy and the tallest – blind -man

Familial Mahvash disease with metastatic pancreatic NET and MEN1 mutations

Serum 5-Hydroxyindoleacetic Acid Measurements for the Diagnosis and Follow-up of Carcinoid Syndrome

Current status of peptide receptor radionuclide therapy in grade 1 and 2 gastroenteropancreatic neuroendocrine tumours

Sidonia and Nicu de Barcsy: a famous mother with post-partum hirsutism after giving birth to a famous son with idiopathic short stature

What Is Carcinoid Syndrome? A Critical Appraisal of Its Proposed Mediators

Glucagon and insulin: 100 years young

Approach to the Patient: Insulinoma

Gut microbial and functional alterations lead to metagenomic signatures for midgut neuroendocrine tumor patients and for carcinoid syndrome

Clinicopathological and epigenetic differences between primary neuroendocrine tumors and neuroendocrine metastases in the ovary

Key Device Attributes for Injectable Somatostatin Receptor Ligand Therapy in Acromegaly and Neuroendocrine Tumours

Neuropathic foot ulcers in the tallest patients with acromegalic gigantism: a common and significant problem. Historical overview

A bronze statue of the acromegalic giant Rigardus Rijnhout

One hundred years after the discovery of insulin and glucagon: the history of tumors and hyperplasias that hypersecrete these hormones

Satisfaction with injection experience of patients with neuroendocrine tumors enrolled on lanreotide autogel patient support programs: Results from the international HomeLAN survey

The Driver Role of Pathologists in Endocrine Oncology: What Clinicians Seek in Pathology Reports

Unfavorable biological behavior and treatment response of neuroendocrine ovarian metastases of midgut neuroendocrine tumors

Proteomic analysis of small intestinal neuroendocrine tumors and mesenteric fibrosis

The science behind the relations among cancer, height, growth patterns, and growth hormone axis

Peptide Receptor Radionuclide Therapy

Collaborators (7)

Robert Kraaij

Marco Volante

Emanuel Christ

Leo Hofland

Lodewijk Brosens

Jens Otto Lunde Jørgensen

Julie Refardt

Make your next move.